Table 1 Serological prevalence of canine vector borne pathogens
Study group | Study population (N) | Overall IFA positivity N (%) | IFA antigens tested | No. of dogs exposed with > 1 IFA antigen | SNAP 4DX® | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Bh SA2 | Bh HI | Bvb I | Bvb II | Bvb III | Bk | Rr | Ec | Bc | Â | Lyme | E. canis | Anaplasma spp | Heartworm |
Group I | 47 | 4 (9%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 2 | 0 | 0 | 0 | 0 |
Group II | 50 | 21 (42%) | 0 | 1 | 0 | 0 | 4 | 0 | 13 | 0 | 0 | 3 | 1 | 8 | 0 | 2 |
Group III | 21 | 4 (19%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 2 | 0 | 4 | 0 | 6 |